A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 165-171

  Muijs, Christina T ^a   Beukema, Jannet C ^a   Pruim, Jan ^b   Mul, Veronique E ^a   Groen, Henk ^b   Plukker, John Th ^b   Langendijk, Johannes A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Esophageal cancer; FDG PET CT; Radiotherapy planning

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER RADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS CANCER; HUMAN; LYMPH NODE METASTASIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77956190524     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.024     Document Type: Review

References (47)

1. G. Antoch, N. Saoudi, and H. Kuehl Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET J Clin Oncol 22 2004 4357 4368
2. R. Bar-Shalom, L. Guralnik, and M. Tsalic The additional value of PET/CT over PET in FDG imaging of oesophageal cancer Eur J Nucl Med Mol Imaging 32 2005 918 924
3. M.I. Block, G.A. Patterson, and R.S. Sundaresan Improvement in staging of esophageal cancer with the addition of positron emission tomography Ann Thorac Surg 64 1997 770 776
4. R. Boellaard Standards for PET image acquisition and quantitative data analysis J Nucl Med 50 2009 11S 20S
5. R. Boellaard, N.C. Krak, and O.S. Hoekstra Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study J Nucl Med 45 2004 1519 1527
6. R. Boellaard, W.J. Oyen, and C.J. Hoekstra The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials Eur J Nucl Med Mol Imaging 35 2008 2320 2333
7. M.R. Button, C.A. Morgan, and E.S. Croydon Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy Int J Radiat Oncol Biol Phys 2008 19
8. 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
9. C. Everitt Leong T Influence of F-fluorodeoxyglucose-positron emission tomography on computed tomography-based radiation treatment planning for oesophageal cancer Australas Radiol 50 2006 271 274
10. P. Flamen, A. Lerut, and E. Van Cutsem Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18 2000 3202 3210
11. V. Gondi, K. Bradley, and M. Mehta Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer Int J Radiat Oncol Biol Phys 67 2007 187 195
12. D. Han, J. Yu, and Y. Yu Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus Int J Radiat Oncol Biol Phys 2009
13. S. Himeno, S. Yasuda, and H. Shimada Evaluation of esophageal cancer by positron emission tomography Jpn J Clin Oncol 32 2002 340 346
14. T.S. Hong, J.H. Killoran, and M. Mamede Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning11 Int J Radiat Oncol Biol Phys 72 2008 1612 1618
15. H. Kato, H. Kimura, and M. Nakajima The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer Oncol Rep 20 2008 857 862
16. H. Kato, H. Kuwano, and M. Nakajima Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 2002 921 928
17. H. Kato, T. Miyazaki, and M. Nakajima The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma Cancer 103 2005 148 156
18. K. Kim, S.J. Park, and B.T. Kim Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography Ann Thorac Surg 71 2001 290 294
19. A.C. Kole, J.T. Plukker, and O.E. Nieweg Positron emission tomography for staging of oesophageal and gastroesophageal malignancy Br J Cancer 78 1998 521 527
20. A. Konski, M. Doss, and B. Milestone The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma Int J Radiat Oncol Biol Phys 61 2005 1123 1128
21. T. Leong, C. Everitt, and K. Yuen A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer Radiother Oncol 78 2006 254 261
22. M. Mamede, G. El Fakhri, and Abreu-e-Lima P Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation14 Ann Nucl Med 21 2007 553 562
23. C.C. Meltzer, J.D. Luketich, and D. Friedman Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography Clin Nucl Med 25 2000 882 887
24. U. Metser Even-Sapir E increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT Semin Nucl Med 37 2007 206 222
25. 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma Int J Radiat Oncol Biol Phys 63 2005 340 345 (Pubitemid 41317149)
26. C.T. Muijs, L.M. Schreurs, and D.M. Busz Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer Radiother Oncol 93 2009 447 453
27. 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 46 2005 1342 1348
28. P.R. Pfau, S.B. Perlman, and P. Stanko The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography Gastrointest Endosc 65 2007 377 384
29. S.C. Rankin, H. Taylor, and G.J. Cook Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma Clin Radiol 53 1998 659 665
30. H.M. Salahudeen, A. Balan, and K. Naik Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma Clin Radiol 63 2008 765 773
31. L.M. Schreurs, D.M. Busz, and G.M. Paardekooper Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability Dis Esophagus 2010
32. L.M. Schreurs, B.B. Pultrum, and K.P. Koopmans Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in oesophageal cancer Anticancer Res 28 2008 1867 1873
33. E.I. Sihvo, J.V. Rasanen, and M.J. Knuuti Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease J Gastrointest Surg 8 2004 988 996
34. G.L. Smith, B.D. Smith, and T.A. Buchholz Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: the SEER-medicare cohort Int J Radiat Oncol Biol Phys 2009
35. J.D. Urschel, and H. Vasan A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer Am J Surg 185 2003 538 543
36. E.P. van Vliet, M.H. Heijenbrok-Kal, and M.G. Hunink Staging investigations for oesophageal cancer: a meta-analysis Br J Cancer 98 2008 547 557
37. 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer J Clin Oncol 22 2004 3805 3812
38. L.J. Vanuytsel, J.F. Vansteenkiste, and S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324
39. 18F)fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography Clin Oncol (R Coll Radiol) 20 2008 631 638
40. O. Vrieze, K. Haustermans, and W. De Wever Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? Radiother Oncol 73 2004 269 275
41. M. Westerterp, H.L. van Westreenen, and J.B. Reitsma Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy s- systematic review Radiology 236 2005 841 851
42. M. Westerterp, H.L. van Westreenen, and G.W. Sloof Role of positron emission tomography in the (re-)staging of oesophageal cancer Scand J Gastroenterol Suppl 2006 116 122
43. S.M. Wren, P. Stijns, and S. Srinivas Positron emission tomography in the initial staging of esophageal cancer Arch Surg 137 2002 1001 1006
44. Y.C. Yoon, K.S. Lee, and Y.M. Shim Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study Radiology 227 2003 764 770
45. 18FDG PET/CT and pathology in esophageal cancer Radiother Oncol 93 2009 441 446
46. S. Yuan, Y. Yu, and K.S. Chao Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer J Nucl Med 47 2006 1255 1259
47. X. Zhong, J. Yu, and B. Zhang Using (18)F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus Int J Radiat Oncol Biol Phys 2008